Choose a language
0 reviews
Xaira Therapeutics is pioneering the integration of artificial intelligence (AI) into drug discovery and development, aiming to transform the creation of life-changing medicines. By combining advanced AI research, extensive data generation, and robust therapeutic product development, Xaira seeks to make biology more computable and shift drug discovery from an empirical science to a precise engineering discipline. Their approach is built on foundational work by co-founder and Nobel Laureate Dr. David Baker, leveraging AI to design entirely new proteins from scratch, enabling the creation of medicines against molecular targets that have been resistant to other approaches.